Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Green Thumb Industries Inc (OP: GTBIF )

7.200 -0.090 (-1.23%)
Streaming Delayed Price Updated: 3:59 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Green Thumb Industries Inc

< Previous 1 2 3 4 5 6 7 8 9
...
37 38 Next >
Cannabis Stock Valuations Reflect No Expectation Of Federal Reform: Study
Viridian Capital's latest report shows cannabis stocks pricing in no rescheduling or 280E relief, leaving MSOs stuck in valuation limbo. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Top Picks For 2025: Green Thumb Industries
The future of cannabis companies is in the hands of politicians. They hold the keys to all the important potential industry reforms. There’s good news and bad news in this. Green Thumb Industries Inc.... 
Via Talk Markets
Topics Cannabis Stocks / Equities
Exposures Cannabis
The Week In Cannabis: Trump's DEA Pick, Tyson's Reform Push, Dutch Coffee Shop Crisis And More
This week in cannabis: DEA shake-up, contaminated cannabis in the Netherlands, and global market updates. 
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
Bearish Sentiment Across The Cannabis Space - Check Full Movers For January 20, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Legalization Headed For The Ballot Again In Florida: Advocates Launch New Amendment Initiative
Group behind failed attempt to legalize recreational cannabis in FL has launched new initiative for 2026 ballot. Allows adult use with limits and restrictions. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Amplify To Liquidate Cannabis-Focused MJUS ETF As Regulatory Uncertainty Weighs On Sector
Amplify ETFs plans to liquidate MJUS, a cannabis-related ETF, due to regulatory issues. Other cannabis ETFs also struggling with DEA's indecisiveness. 
Via Benzinga
Topics Cannabis ETFs
Exposures Cannabis
DEA Accused Of Bias In Cannabis Rescheduling Hearings: Weed Stocks Plummeted In 2024 As Process Drags On
DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
EXCLUSIVE: Cannabis Physician Says Surgeon General's Alcohol Cancer Risk Warning Is 'Wake-Up Call'
Surgeon general warns about alcohol's cancer risk, suggests updates to health labels. Cannabis stocks largely rise while alcohol stocks drop. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Price Is Right: This Weed Real Estate Stock Proves Conservative Strategies Bring Returns
New Lake Capital Partners (OTC:NLCP), a real estate company focused on cannabis properties, offers an attractive investment with a 9.1% dividend yield, well above the return on 10-year government... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
85% Of Cannabis Companies Report Positive Earnings, But Not All Are Winning - See Who's Leading
85% of the companies analyzed by Beacon Securities achieved positive adjusted EBITDA for the quarter, an increase from 81% in Q2. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Why Cannabis Sales Are Down In Massachusetts And New Mexico: The Numbers Behind The Dip
Massachusetts' average revenue per dispensary dropped to $362k/month, down 8% year-over-year, in New Mexico sales went down 3% in November. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Illinois Cannabis Sales Back On Track In October Hitting $142.3M After Slight September Dip
ollowing a drop in September cannabis sales numbers in Illinois, October figures totaled $142.3 million, a 4.2% increase sequentially, reported New Cannabis Ventures' Alan Brochstein. Cannabis sales... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat?
For investors, MariMed represents a fundamentally strong outlier, but industry-wide challenges remain a drag on stock performance. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Diversify Around And Find Out: Can Vegas Superstore And Florida Sales Boost This Weed Penny Stock?
Is this 40-cent cannabis stock undervalued? Zuanic & Associates dives into its growth potential and market prospects. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Pharma-Grade Cannabis Could Hit Walgreens & CVS—But Can The Industry Survive The FDA?
As the formal review process for rescheduling cannabis unfolds, industry players are closely watching its potential to transform the sector. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Co. Cansortium Refinances Debt With $96.5M Loan Ahead Of Major Merger And Next Phase Of Growth
Cansortium Inc. (CSE: TIUM.U) (OTCQB: CNTMF) announced on Tuesday that it has secured a new senior secured credit agreement of up to $96.5 million with Chicago Atlantic Admin, LLC, as an administrative... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Federal Policy Could Add $3 Billion To Cannabis Industry: On Track To Reach $55 Billion By 2030
According to LeafLink, over the next 2-3 years, 5,000 non-MSO retailers are projected to open in key states, increasing store counts by 70%. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
80% Leverage, 5.5x EBITDA: Is Cresco The High-Risk, High-Reward Play Investors Need?
According to Z&A, its enterprise value (EV) to current sales ratio stands at 1.6x, lower than Curaleaf and Green Thumb, both at 2.2x. 
Via Benzinga
Best And Worst Performing States For Cannabis Sales In 2024: YTD Winners & Losers
BDSA's October 2024 data highlights Maryland as the fastest-growing state for cannabis sales, with a year-to-date increase of 57.8%. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump's Attorney General Nominee
The AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS), often viewed as a benchmark for MSOs, dropped by -4.31%, closing at $4.56. 
Via Benzinga
Topics Cannabis ETFs Government
Exposures Cannabis Political
Pre-Rolls, The Avocado Toast Of Cannabis: Why Millennials Are Spending +$100M A Month
Millennials dominate the pre-roll market, accounting for 44.6% of purchases in September 2024, totaling $103.9 million. 
Via Benzinga
Can Trump's Return Save The Cannabis Sector? Debt Mounts As Giants Face Post-Election Reckoning
The post-election landscape raises uncertainty for cannabis MSOs, with investors hoping for potential relief from the new administration. 
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
Medical Marijuana Footprint Grows In Florida As Legalization Push Fizzles, And Other New Cannabis Stores
RISE Dispensaries, a cannabis retail chain owned by Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF), opened RISE Dispensary Orlando on Good Homes Road on Friday, Nov. 8. Located at 725 Good... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Agrify's Q3 Revenue Drop, $18.6M Loss Amid New Leadership
Agrify Q3 financial results: $1.9M revenue, $18.6M net loss. New $20M financing and hemp beverage acquisition aim to drive growth. 
Via Benzinga
Trump Nominates Another Cannabis Supporter To Cabinet: Rep. Matt Gaetz For Attorney General
Donald Trump nominated Rep. Matt Gaetz as attorney general, who has supported cannabis legalization and proposed ending cannabis testing for military recruitment. 
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
Does the Rejection of Top Marijuana Legalization Measures Doom the Pot Industry?
The American electorate seems to have turned against weed legal reform. 
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
Three Paths To Cannabis Profits: Village Farms, Green Thumb, And Jushi Show Divergent Strategies—Which Will Deliver?
Cannabis giants Village Farms, Green Thumb, and Jushi Holdings show distinct strategies for navigating a challenging landscape. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Plunged After Florida Legalization Failed: Rational Reaction Or Market Overreach?
Florida's failed adult-use cannabis vote led to a $2.6B loss in market cap. Was the market reaction justified? Earnings data adds uncertainty. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Green Thumb Q3 Results Show 58% Decline In Net Income And 5% Decline In EBITDA
Green Thumb's Q3 financial metrics were poor across the board. 
Via Talk Markets
Green Thumb Grows Revenue To $287M In Q3, Expands Cannabis Retail Network
Green Thumb Industries Q3: $287M revenue, $9M profit, debt reduced, 4 new dispensaries, $50M share buyback approved, retail network expands. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
< Previous 1 2 3 4 5 6 7 8 9
...
37 38 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback